New insights into the HCV quasispecies and compartmentalization

Seminars in Liver Disease

Volumn 31, Issue 4, 2011, Pages 356-374

  Farci, Patrizia ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

compartmentalism; Hepatitis C virus; immune escape; quasispecies; viral persistence

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; PEGINTERFERON ALPHA; PEGINTERFERON ALPHA2A; RIBAVIRIN;

ADAPTIVE IMMUNITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELLULAR IMMUNITY; DISEASE COURSE; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMORAL IMMUNITY; LIVER TRANSPLANTATION; MOLECULAR EVOLUTION; NONHUMAN; PATHOGENESIS; PRIMARY INFECTION; PRIORITY JOURNAL; TREATMENT RESPONSE; VIRUS GENE; VIRUS LOAD; VIRUS MUTATION; VIRUS REPLICATION; VIRUS STRAIN;

ANTIGENIC VARIATION; CONSENSUS SEQUENCE; DRUG RESISTANCE, VIRAL; EVOLUTION, MOLECULAR; GENETIC HETEROGENEITY; HEPACIVIRUS; HUMANS; MUTATION; MUTATION RATE; RNA, VIRAL; VIRAL PROTEINS;

EID: 84455189499     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0031-1297925     Document Type: Article

References (230)

1. Domingo E, Sabo D, Taniguchi T, Weissmann C. Nucleotide sequence heterogeneity of an RNA phage population. Cell 1978 13 4 735-744 (Pubitemid 8312229)
2. Domingo E, Wain-Hobson S. The 30th anniversary of quasispecies. Meeting on Quasispecies: past, present and future EMBO Rep 2009 10 5 444-448
3. Eigen M. Selforganization of matter and the evolution of biological macromolecules. Naturwissenschaften 1971 58 10 465-523
4. Eigen M, Schuster P. The Hypercycle. A Principle of Natural Self-Organization. Berlin Springer-Verlag 1979
5. Houghton M. Hepatitis C virus. In: Fields B N. Knipe D M. Howley P M. Chanock R H. eds. Fields Virology. 3rd ed. Philadelphia, PA Lippincott-Raven 1996 1035-1058
6. Lindenbach B D., Rice C M. Unravelling hepatitis C virus replication from genome to function. Nature 2005 436 7053 933-938 (Pubitemid 41191668)
7. Branch A D., Stump D D., Gutierrez J A., Eng F, Walewski J L. The hepatitis C virus alternate reading frame (ARF) and its family of novel products: the alternate reading frame protein/F-protein, the double-frameshift protein, and others. Semin Liver Dis 2005 25 1 105-117 (Pubitemid 40322355)
8. Holland J, Spindler K, Horodyski F, Grabau E, Nichol S, VandePol S. Rapid evolution of RNA genomes. Science 1982 215 4540 1577-1585 (Pubitemid 12102984)
9. Domingo E. Virus evolution. In: Knipe D M. Howley P F. eds. Fields Virology. 5th ed. Philadelphia, PA Lippincott Williams & Wilkins 2007 389-421
10. Duffy S, Shackelton L A., Holmes E C. Rates of evolutionary change in viruses: patterns and determinants. Nat Rev Genet 2008 9 4 267-276 (Pubitemid 351399833)
11. Holland J J., Domingo E, de la Torre J C., Steinhauer D A. Mutation frequencies at defined single codon sites in vesicular stomatitis virus and poliovirus can be increased only slightly by chemical mutagenesis. J Virol 1990 64 8 3960-3962 (Pubitemid 20227220)
12. Crotty S, Cameron C E., Andino R. RNA virus error catastrophe: direct molecular test by using ribavirin. Proc Natl Acad Sci U S A 2001 98 12 6895-6900 (Pubitemid 32538313)
13. Kalinina O, Norder H, Mukomolov S, Magnius L O. A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol 2002 76 8 4034-4043 (Pubitemid 34250567)
14. Yokoyama K, Takahashi M, Nishizawa T et al. Identification and characterization of a natural inter-genotypic (2b/1b) recombinant hepatitis C virus in Japan. Arch Virol 2011 156 9 1591-1601
15. Neumann A U., Lam N P., Dahari H et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 1998 282 5386 103-107 (Pubitemid 28471138)
16. Martell M, Esteban J I., Quer J et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1992 66 5 3225-3229
17. de la Torre J C., Holland J J. RNA virus quasispecies populations can suppress vastly superior mutant progeny. J Virol 1990 64 12 6278-6281
18. Domingo E, Martin V, Perales C et al. Viruses as quasispecies: biological implications. Curr Top Microbiol Immunol 2006 299 51-82 (Pubitemid 43086561)
19. Domingo E, Holland J J. RNA virus mutations and fitness for survival. Annu Rev Microbiol 1997 51 151-178 (Pubitemid 27433046)
20. Ruiz-Jarabo C M., Arias A, Baranowski E, Escarmis C, Domingo E. Memory in viral quasispecies. J Virol 2000 74 8 3543-3547 (Pubitemid 30180296)
21. Eigen M, Biebricher C K. Sequence space and quasispecies distribution. In: Domingo E Ahlquist P Holland J J. eds. RNA Genetics. Vol. 3. Boca Raton, FL CRC Press 1988 211-245
22. Steinhauer D A., Holland J J. Rapid evolution of RNA viruses. Annu Rev Microbiol 1987 41 409-433
23. Ogata N, Alter H J., Miller R H., Purcell R H. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci U S A 1991 88 8 3392-3396 (Pubitemid 21916627)
24. Okamoto H, Kojima M, Okada S et al. Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. Virology 1992 190 2 894-899
25. Lu L, Nakano T, Orito E, Mizokami M, Robertson B H. Evaluation of accumulation of hepatitis C virus mutations in a chronically infected chimpanzee: comparison of the core, E1, HVR1, and NS5b regions. J Virol 2001 75 6 3004-3009 (Pubitemid 32185066)
26. Farci P, Alter H J., Wong D et al. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med 1991 325 2 98-104
27. Thimme R, Oldach D, Chang K M., Steiger C, Ray S C., Chisari F V. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001 194 10 1395-1406 (Pubitemid 33081515)
28. Rehermann B. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J Clin Invest 2009 119 7 1745-1754
29. Walker C M. Adaptive immunity to the hepatitis C virus. Adv Virus Res 2010 78 43-86
30. Dahari H, Major M, Zhang X et al. Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production. Gastroenterology 2005 128 4 1056-1066 (Pubitemid 40523555)
31. Su A I., Pezacki J P., Wodicka L et al. Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci U S A 2002 99 24 15669-15674 (Pubitemid 35403989)
32. Gale M Jr, Foy E M. Evasion of intracellular host defence by hepatitis C virus. Nature 2005 436 7053 939-945 (Pubitemid 41191669)
33. Thimme R, Bukh J, Spangenberg H C. et al. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci U S A 2002 99 24 15661-15668 (Pubitemid 35403988)
34. Bertoletti A, Ferrari C. Kinetics of the immune response during HBV and HCV infection. Hepatology 2003 38 1 4-13 (Pubitemid 36775788)
35. Lohmann V, Körner F, Koch J, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999 285 5424 110-113 (Pubitemid 29307577)
36. Lohmann V, Körner F, Dobierzewska A, Bartenschlager R. Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J Virol 2001 75 3 1437-1449 (Pubitemid 32094702)
37. Blight K J., Kolykhalov A A., Rice C M. Efficient initiation of HCV RNA replication in cell culture. Science 2000 290 5498 1972-1974
38. Smith D B., Mellor J, Jarvis L M. et al, The International HCV Collaborative Study Group. Variation of the hepatitis C virus 5 non-coding region: implications for secondary structure, virus detection and typing. J Gen Virol 1995 76 Pt 7 1749-1761
39. Bukh J, Miller R H., Purcell R H. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 1995 15 1 41-63
40. Bukh J, Pietschmann T, Lohmann V et al. Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees. Proc Natl Acad Sci U S A 2002 99 22 14416-14421 (Pubitemid 35257686)
41. Ray S C., Mao Q, Lanford R E. et al. Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees. J Virol 2000 74 7 3058-3066 (Pubitemid 30143728)
42. Prince A M., Pawlotsky J M., Soulier A et al. Hepatitis C virus replication kinetics in chimpanzees with self-limited and chronic infections. J Viral Hepat 2004 11 3 236-242 (Pubitemid 38658448)
43. Bassett S E., Thomas D L., Brasky K M., Lanford R E. Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees. J Virol 1999 73 2 1118-1126 (Pubitemid 29036763)
44. Bukh J. A critical role for the chimpanzee model in the study of hepatitis C. Hepatology 2004 39 6 1469-1475 (Pubitemid 38702645)
45. Gómez J, Martell M, Quer J, Cabot B, Esteban J I. Hepatitis C viral quasispecies. J Viral Hepat 1999 6 1 3-16 (Pubitemid 29077621)
46. Forns X, Bukh J, Purcell R H., Emerson S U. How Escherichia coli can bias the results of molecular cloning: preferential selection of defective genomes of hepatitis C virus during the cloning procedure. Proc Natl Acad Sci U S A 1997 94 25 13909-13914 (Pubitemid 28009683)
47. Fishman S L., Branch A D. The quasispecies nature and biological implications of the hepatitis C virus. Infect Genet Evol 2009 9 6 1158-1167
48. Verbinnen T, Van Marck H, Vandenbroucke I et al. Tracking the evolution of multiple in vitro hepatitis C virus replicon variants under protease inhibitor selection pressure by 454 deep sequencing. J Virol 2010 84 21 11124-11133
49. Hiraga N, Imamura M, Abe H et al. Rapid emergence of telaprevir resistant hepatitis C virus strain from wildtype clone in vivo. Hepatology 2011 Epub ahead of print
50. Wang G P., Sherrill-Mix S A., Chang K M., Quince C, Bushman F D. Hepatitis C virus transmission bottlenecks analyzed by deep sequencing. J Virol 2010 84 12 6218-6228
51. Bull R A., Luciani F, McElroy K et al. Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection. PLoS Pathog 2011 7 9 e1002243
52. Zinkernagel R M. On natural and artificial vaccinations. Annu Rev Immunol 2003 21 515-546 (Pubitemid 37174540)
53. Farci P, Alter H J., Wong D C. et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci U S A 1994 91 16 7792-7796
54. Shimizu Y K., Hijikata M, Iwamoto A et al. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 1994 68 3 1494-1500 (Pubitemid 24065713)
55. Farci P, Shimoda A, Wong D et al. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci U S A 1996 93 26 15394-15399 (Pubitemid 27009611)
56. Shimizu Y K., Igarashi H, Kiyohara T et al. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. Virology 1996 223 2 409-412 (Pubitemid 26319606)
57. Weiner A J., Geysen H M., Christopherson C et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci U S A 1992 89 8 3468-3472
58. Zeisel M B., Fafi-Kremer S, Fofana I et al. Neutralizing antibodies in hepatitis C virus infection. World J Gastroenterol 2007 13 36 4824-4830 (Pubitemid 47496747)
59. Zibert A, Meisel H, Kraas W et al. Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus. Hepatology 1997 25 5 1245-1249 (Pubitemid 27199955)
60. Kumar U, Monjardino J, Thomas H C. Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient. Gastroenterology 1994 106 4 1072-1075 (Pubitemid 24109297)
61. Booth J C., Kumar U, Webster D, Monjardino J, Thomas H C. Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients. Hepatology 1998 27 1 223-227 (Pubitemid 28041558)
62. Prince A M., Brotman B, Lee D H. et al. Significance of the anti-E2 response in self-limited and chronic hepatitis C virus infections in chimpanzees and in humans. J Infect Dis 1999 180 4 987-991 (Pubitemid 30070178)
63. Major M E., Dahari H, Mihalik K et al. Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees. Hepatology 2004 39 6 1709-1720 (Pubitemid 38702673)
64. Bartosch B, Dubuisson J, Cosset F L. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med 2003 197 5 633-642 (Pubitemid 36314658)
65. Hsu M, Zhang J, Flint M et al. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci U S A 2003 100 12 7271-7276 (Pubitemid 36706428)
66. Baumert T F., Ito S, Wong D T., Liang T J. Hepatitis C virus structural proteins assemble into viruslike particles in insect cells. J Virol 1998 72 5 3827-3836 (Pubitemid 28188682)
67. Wakita T, Pietschmann T, Kato T et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005 11 7 791-796 (Pubitemid 41021213)
68. Lindenbach B D., Evans M J., Syder A J. et al. Complete replication of hepatitis C virus in cell culture. Science 2005 309 5734 623-626 (Pubitemid 41033648)
69. Bartosch B, Bukh J, Meunier J C. et al. In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Proc Natl Acad Sci U S A 2003 100 24 14199-14204 (Pubitemid 37499214)
70. Meunier J C., Engle R E., Faulk K et al. Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proc Natl Acad Sci U S A 2005 102 12 4560-4565 (Pubitemid 40397151)
71. Logvinoff C, Major M E., Oldach D et al. Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc Natl Acad Sci U S A 2004 101 27 10149-10154 (Pubitemid 38891210)
72. Meunier J C., Bukh J, Diaz G et al. Neutralizing antibodies to HCV in perinatally infected children followed prospectively. J Infect Dis 2011 204 11 1741-1745
73. Pestka J M., Zeisel M B., Bliser E et al. Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C. Proc Natl Acad Sci U S A 2007 104 14 6025-6030 (Pubitemid 47175652)
74. von Hahn T, Yoon J C., Alter H et al. Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology 2007 132 2 667-678 (Pubitemid 46274668)
75. Dowd K A., Netski D M., Wang X H., Cox A L., Ray S C. Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus. Gastroenterology 2009 136 7 2377-2386
76. Lavillette D, Morice Y, Germanidis G et al. Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection. J Virol 2005 79 10 6023-6034 (Pubitemid 40617208)
77. Bukh J, Thimme R, Meunier J C. et al. Previously infected chimpanzees are not consistently protected against reinfection or persistent infection after reexposure to the identical hepatitis C virus strain. J Virol 2008 82 16 8183-8195
78. Penin F, Combet C, Germanidis G, Frainais P O., Deléage G, Pawlotsky J M. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. J Virol 2001 75 12 5703-5710 (Pubitemid 32488166)
79. Vieyres G, Dubuisson J, Patel A H. Characterization of antibody-mediated neutralization directed against the hypervariable region 1 of hepatitis C virus E2 glycoprotein. J Gen Virol 2011 92 Pt 3 494-506
80. Prentoe J, Jensen T B., Meuleman P et al. Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization. J Virol 2011 85 5 2224-2234
81. Forns X, Thimme R, Govindarajan S et al. Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees. Proc Natl Acad Sci U S A 2000 97 24 13318-13323
82. Bankwitz D, Steinmann E, Bitzegeio J et al. Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes. J Virol 2010 84 11 5751-5763
83. Zolla-Pazner S, Cardozo T. Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design. Nat Rev Immunol 2010 10 7 527-535
84. Ray S C., Wang Y M., Laeyendecker O, Ticehurst J R., Villano S A., Thomas D L. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy. J Virol 1999 73 4 2938-2946 (Pubitemid 29135682)
85. Keck Z Y., Op De Beeck A, Hadlock K G. et al. Hepatitis C virus E2 has three immunogenic domains containing conformational epitopes with distinct properties and biological functions. J Virol 2004 78 17 9224-9232 (Pubitemid 39096532)
86. Keck Z Y., Li S H., Xia J et al. Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity. J Virol 2009 83 12 6149-6160
87. Diepolder H M., Zachoval R, Hoffmann R M. et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995 346 8981 1006-1007
88. Gerlach J T., Diepolder H M., Jung M C. et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology 1999 117 4 933-941 (Pubitemid 29468237)
89. Cooper S, Erickson A L., Adams E J. et al. Analysis of a successful immune response against hepatitis C virus. Immunity 1999 10 4 439-449 (Pubitemid 29205480)
90. Lechner F, Wong D K., Dunbar P R. et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000 191 9 1499-1512 (Pubitemid 30257347)
91. Grakoui A, Shoukry N H., Woollard D J. et al. HCV persistence and immune evasion in the absence of memory T cell help. Science 2003 302 5645 659-662 (Pubitemid 37310924)
92. Shoukry N H., Grakoui A, Houghton M et al. Memory CD8+T cells are required for protection from persistent hepatitis C virus infection. J Exp Med 2003 197 12 1645-1655 (Pubitemid 36745340)
93. Gottwein J M., Scheel T K., Callendret B et al. Novel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in vivo pathogenesis studies. J Virol 2010 84 10 5277-5293
94. Klenerman P, Thimme R. T cell responses in hepatitis C: the good, the bad and the unconventional. Gut 2011 Epub ahead of print
95. Bengsch B, Seigel B, Ruhl M et al. Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+T cells is linked to antigen recognition and T cell differentiation. PLoS Pathog 2010 6 6 e1000947
96. Neumann-Haefelin C, Thimme R. Success and failure of virus-specific T cell responses in hepatitis C virus infection. Dig Dis 2011 29 4 416-422
97. Weiner A, Erickson A L., Kansopon J et al. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc Natl Acad Sci U S A 1995 92 7 2755-2759
98. Erickson A L., Kimura Y, Igarashi S et al. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity 2001 15 6 883-895 (Pubitemid 34075370)
99. Chang K M., Rehermann B, McHutchison J G. et al. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. J Clin Invest 1997 100 9 2376-2385 (Pubitemid 27500163)
100. Timm J, Lauer G M., Kavanagh D G. et al. CD8 epitope escape and reversion in acute HCV infection. J Exp Med 2004 200 12 1593-1604 (Pubitemid 40094183)
101. Bowen D G., Walker C M. Mutational escape from CD8+T cell immunity: HCV evolution, from chimpanzees to man. J Exp Med 2005 201 11 1709-1714 (Pubitemid 41002889)
102. Cox A L., Mosbruger T, Mao Q et al. Cellular immune selection with hepatitis C virus persistence in humans. J Exp Med 2005 201 11 1741-1752 (Pubitemid 41002893)
103. Ray S C., Fanning L, Wang X H. et al. Divergent and convergent evolution after a common-source outbreak of hepatitis C virus. J Exp Med 2005 201 11 1753-1759 (Pubitemid 41002894)
104. Tsai S L., Chen Y M., Chen M H. et al. Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity. Gastroenterology 1998 115 4 954-965
105. Guglietta S, Garbuglia A R., Salichos L et al. Impact of viral selected mutations on T cell mediated immunity in chronically evolving and self limiting acute HCV infection. Virology 2009 386 2 398-406
106. Tester I, Smyk-Pearson S, Wang P et al. Immune evasion versus recovery after acute hepatitis C virus infection from a shared source. J Exp Med 2005 201 11 1725-1731 (Pubitemid 41002891)
107. Fernandez J, Taylor D, Morhardt D R. et al. Long-term persistence of infection in chimpanzees inoculated with an infectious hepatitis C virus clone is associated with a decrease in the viral amino acid substitution rate and low levels of heterogeneity. J Virol 2004 78 18 9782-9789 (Pubitemid 39187096)
108. Kuntzen T, Timm J, Berical A et al. Viral sequence evolution in acute hepatitis C virus infection. J Virol 2007 81 21 11658-11668 (Pubitemid 47623798)
109. Ruhl M, Knuschke T, Schewior K et al, East German HCV Study Group. CD8+T-cell response promotes evolution of hepatitis C virus nonstructural proteins. Gastroenterology 2011 140 7 2064-2073
110. Neumann-Haefelin C, McKiernan S, Ward S et al. Dominant influence of an HLA-B27 restricted CD8+T cell response in mediating HCV clearance and evolution. Hepatology 2006 43 3 563-572
111. Kim A Y., Kuntzen T, Timm J et al. Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes. Gastroenterology 2011 140 2 686-696, e1
112. Cox A L., Mosbruger T, Lauer G M., Pardoll D, Thomas D L., Ray S C. Comprehensive analyses of CD8+T cell responses during longitudinal study of acute human hepatitis C. Hepatology 2005 42 1 104-112 (Pubitemid 40911317)
113. Neumann-Haefelin C, Timm J, Spangenberg H C. et al. Virological and immunological determinants of intrahepatic virus-specific CD8+T-cell failure in chronic hepatitis C virus infection. Hepatology 2008 47 6 1824-1836 (Pubitemid 351945550)
114. Komatsu H, Lauer G, Pybus O G. et al. Do antiviral CD8+T cells select hepatitis C virus escape mutants? Analysis in diverse epitopes targeted by human intrahepatic CD8+T lymphocytes. J Viral Hepat 2006 13 2 121-130
115. Uebelhoer L, Han J H., Callendret B et al. Stable cytotoxic T cell escape mutation in hepatitis C virus is linked to maintenance of viral fitness. PLoS Pathog 2008 4 9 e1000143
116. Liu L, Fisher B E., Dowd K A., Astemborski J, Cox A L., Ray S C. Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection. J Virol 2010 84 10 5067-5077
117. Wang H, Eckels D D. Mutations in immunodominant T cell epitopes derived from the nonstructural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T cell recognition. J Immunol 1999 162 7 4177-4183 (Pubitemid 29314804)
118. Fleming V M., Harcourt G, Barnes E, Klenerman P. Virological footprint of CD4+T-cell responses during chronic hepatitis C virus infection. J Gen Virol 2010 91 Pt 6 1396-1406
119. Fuller M J., Shoukry N H., Gushima T et al. Selection-driven immune escape is not a significant factor in the failure of CD4 T cell responses in persistent hepatitis C virus infection. Hepatology 2010 51 2 378-387
120. Farci P, Quinti I, Farci S et al. Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively. Proc Natl Acad Sci U S A 2006 103 22 8475-8480 (Pubitemid 43838480)
121. Farci P, Shimoda A, Coiana A et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 2000 288 5464 339-344 (Pubitemid 30226196)
122. Laskus T, Wilkinson J, Gallegos-Orozco J F. et al. Analysis of hepatitis C virus quasispecies transmission and evolution in patients infected through blood transfusion. Gastroenterology 2004 127 3 764-776 (Pubitemid 39208410)
123. Farci P, Strazzera R, Alter H J. et al. Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome. Proc Natl Acad Sci U S A 2002 99 5 3081-3086 (Pubitemid 34240589)
124. Manzin A, Solforosi L, Debiaggi M et al. Dominant role of host selective pressure in driving hepatitis C virus evolution in perinatal infection. J Virol 2000 74 9 4327-4334 (Pubitemid 30214441)
125. Urbani S, Amadei B, Cariani E et al. The impairment of CD8 responses limits the selection of escape mutations in acute hepatitis C virus infection. J Immunol 2005 175 11 7519-7529 (Pubitemid 41713450)
126. Alter H J., Seeff L B. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis 2000 20 1 17-35 (Pubitemid 30421406)
127. Yeo A E., Ghany M, Conry-Cantilena C et al. Stability of HCV-RNA level and its lack of correlation with disease severity in asymptomatic chronic hepatitis C virus carriers. J Viral Hepat 2001 8 4 256-263 (Pubitemid 32673736)
128. Honda M, Kaneko S, Sakai A, Unoura M, Murakami S, Kobayashi K. Degree of diversity of hepatitis C virus quasispecies and progression of liver disease. Hepatology 1994 20 5 1144-1151 (Pubitemid 24323558)
129. Koizumi K, Enomoto N, Kurosaki M et al. Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology 1995 22 1 30-35
130. Hayashi J, Kishihara Y, Yamaji K et al. Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection. Hepatology 1997 25 3 697-701 (Pubitemid 27106456)
131. Yuki N, Hayashi N, Moribe T et al. Relation of disease activity during chronic hepatitis C infection to complexity of hypervariable region 1 quasispecies. Hepatology 1997 25 2 439-444 (Pubitemid 27069069)
132. Naito M, Hayashi N, Moribe T et al. Hepatitis C viral quasispecies in hepatitis C virus carriers with normal liver enzymes and patients with type C chronic liver disease. Hepatology 1995 22 2 407-412
133. López-Labrador F X., Ampurdanis S, Giménez-Barcons M et al. Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection [correction of interferon]. Hepatology 1999 29 3 897-903 (Pubitemid 29109607)
134. Leone F, Zylberberg H, Squadrito G et al. Hepatitis C virus (HCV) hypervariable region 1 complexity does not correlate with severity of liver disease, HCV type, viral load or duration of infection. J Hepatol 1998 29 5 689-694 (Pubitemid 28505923)
135. Rothman A L., Morishima C, Bonkovsky H L. et al, HALT-C Trial Group. Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis C. Hepatology 2005 41 3 617-625 (Pubitemid 40289511)
136. Sullivan D G., Bruden D, Deubner H et al. Hepatitis C virus dynamics during natural infection are associated with long-term histological outcome of chronic hepatitis C disease. J Infect Dis 2007 196 2 239-248 (Pubitemid 47047463)
137. Izopet J, Rostaing L, Sandres K et al. Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients. J Infect Dis 2000 181 3 852-858 (Pubitemid 30194465)
138. Qin H, Shire N J., Keenan E D. et al, Multicenter Hemophilia Cohort Study Group. HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV. Blood 2005 105 2 533-541 (Pubitemid 40070732)
139. Tagariello G, Gerotto M, Pontisso P et al. Hepatitis C virus quasispecies in the natural course of HCV-related disease in patients with haemophilia. Haemophilia 2004 10 1 81-86 (Pubitemid 38195630)
140. Wang X H., Netski D M., Astemborski J et al. Progression of fibrosis during chronic hepatitis C is associated with rapid virus evolution. J Virol 2007 81 12 6513-6522 (Pubitemid 46878056)
141. Ramirez S, Pérez-Del-Pulgar S, Forns X. Virology and pathogenesis of hepatitis C virus recurrence. Liver Transpl 2008 14 Suppl 2 S27-S35
142. Feliu A, Gay E, Garcia-Retortillo M, Saiz J C., Forns X. Evolution of hepatitis C virus quasispecies immediately following liver transplantation. Liver Transpl 2004 10 9 1131-1139 (Pubitemid 39248410)
143. Gretch D R., Polyak S J., Wilson J J., Carithers R L. Jr, Perkins J D., Corey L. Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. J Virol 1996 70 11 7622-7631 (Pubitemid 26339067)
144. Sullivan D G., Wilson J J., Carithers R L. Jr, Perkins J D., Gretch D R. Multigene tracking of hepatitis C virus quasispecies after liver transplantation: correlation of genetic diversification in the envelope region with asymptomatic or mild disease patterns. J Virol 1998 72 12 10036-10043 (Pubitemid 28520872)
145. Sánchez-Fueyo A, Giménez-Barcons M, Puig-Basagoiti F et al. Influence of the dynamics of the hypervariable region 1 of hepatitis C virus (HCV) on the histological severity of HCV recurrence after liver transplantation. J Med Virol 2001 65 2 266-275
146. Lyra A C., Fan X, Lang D M. et al. Evolution of hepatitis C viral quasispecies after liver transplantation. Gastroenterology 2002 123 5 1485-1493 (Pubitemid 35231648)
147. Arenas J I., Gallegos-Orozco J F., Laskus T et al. Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation. J Infect Dis 2004 189 11 2037-2046 (Pubitemid 38692284)
148. Li H, Sullivan D G., Feuerborn N et al. Genetic diversity of hepatitis C virus predicts recurrent disease after liver transplantation. Virology 2010 402 2 248-255
149. Lerat H, Berby F, Trabaud M A. et al. Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J Clin Invest 1996 97 3 845-851 (Pubitemid 26057104)
150. Radkowski M, Wang L F., Vargas H E., Rakela J, Laskus T. Detection of hepatitis C virus replication in peripheral blood mononuclear cells after orthotopic liver transplantation. Transplantation 1998 66 5 664-666 (Pubitemid 28433854)
151. Laskus T, Radkowski M, Piasek A et al. Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes. J Infect Dis 2000 181 2 442-448 (Pubitemid 30131808)
152. Radkowski M, Wilkinson J, Nowicki M et al. Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol 2002 76 2 600-608 (Pubitemid 34033359)
153. Laskus T, Radkowski M, Wilkinson J, Vargas H, Rakela J. The origin of hepatitis C virus reinfecting transplanted livers: serum-derived versus peripheral blood mononuclear cell-derived virus. J Infect Dis 2002 185 4 417-421 (Pubitemid 34142802)
154. Ducoulombier D, Roque-Afonso A M., Di Liberto G et al. Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes. Hepatology 2004 39 3 817-825 (Pubitemid 38337663)
155. Roque-Afonso A M., Ducoulombier D, Di Liberto G et al. Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J Virol 2005 79 10 6349-6357 (Pubitemid 40617238)
156. Bagaglio S, Cinque P, Racca S et al. Hepatitis C virus populations in the plasma, peripheral blood mononuclear cells and cerebrospinal fluid of HIV/hepatitis C virus-co-infected patients. AIDS 2005 19 Suppl 3 S151-S165 (Pubitemid 41683151)
157. Pal S, Sullivan D G., Kim S et al. Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism. Gastroenterology 2006 130 4 1107-1116
158. Blackard J T., Hiasa Y, Smeaton L et al. Compartmentalization of hepatitis C virus (HCV) during HCV/HIV coinfection. J Infect Dis 2007 195 12 1765-1773 (Pubitemid 46870249)
159. McGuinness P H., Bishop G A., McCaughan G W., Trowbridge R, Gowans E J. False detection of negative-strand hepatitis C virus RNA. Lancet 1994 343 8896 551-552 (Pubitemid 24062315)
160. Lanford R E., Chavez D, Chisari F V., Sureau C. Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR. J Virol 1995 69 12 8079-8083
161. Laskus T, Radkowski M, Wang L F., Cianciara J, Vargas H, Rakela J. Hepatitis C virus negative strand RNA is not detected in peripheral blood mononuclear cells and viral sequences are identical to those in serum: a case against extrahepatic replication. J Gen Virol 1997 78 Pt 11 2747-2750 (Pubitemid 27480812)
162. Quadri R, Rubbia-Brandt L, Abid K, Negro F. Detection of the negative-strand hepatitis C virus RNA in tissues: implications for pathogenesis. Antiviral Res 2001 52 2 161-171 (Pubitemid 32973691)
163. Madejón A, Manzano M L., Arocena C, Castillo I, Carreio V. Effects of delayed freezing of liver biopsies on the detection of hepatitis C virus RNA strands. J Hepatol 2000 32 6 1019-1025 (Pubitemid 30368096)
164. Natarajan V, Kottilil S, Hazen A et al. HCV in peripheral blood mononuclear cells are predominantly carried on the surface of cells in HIV/HCV co-infected individuals. J Med Virol 2010 82 12 2032-2037
165. Pham T N., King D, Macparland S A. et al. Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection. Gastroenterology 2008 134 3 812-822 (Pubitemid 351312726)
166. Fujii K, Hino K, Okazaki M, Okuda M, Kondoh S, Okita K. Differences in hypervariable region 1 quasispecies of hepatitis C virus between human serum and peripheral blood mononuclear cells. Biochem Biophys Res Commun 1996 225 3 771-776 (Pubitemid 26319181)
167. Cabot B, Esteban J I., Martell M et al. Structure of replicating hepatitis C virus (HCV) quasispecies in the liver may not be reflected by analysis of circulating HCV virions. J Virol 1997 71 2 1732-1734 (Pubitemid 27030358)
168. Shimizu Y K., Igarashi H, Kanematu T et al. Sequence analysis of the hepatitis C virus genome recovered from serum, liver, and peripheral blood mononuclear cells of infected chimpanzees. J Virol 1997 71 8 5769-5773 (Pubitemid 27304911)
169. Maggi F, Fornai C, Vatteroni M L. et al. Differences in hepatitis C virus quasispecies composition between liver, peripheral blood mononuclear cells and plasma. J Gen Virol 1997 78 Pt 7 1521-1525 (Pubitemid 27343088)
170. Navas S, Martin J, Quiroga J A., Castillo I, Carreio V. Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients. J Virol 1998 72 2 1640-1646 (Pubitemid 28116955)
171. Maggi F, Fornai C, Morrica A et al. Divergent evolution of hepatitis C virus in liver and peripheral blood mononuclear cells of infected patients. J Med Virol 1999 57 1 57-63 (Pubitemid 28553380)
172. Okuda M, Hino K, Korenaga M, Yamaguchi Y, Katoh Y, Okita K. Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum, peripheral blood mononuclear cells, and liver. Hepatology 1999 29 1 217-222 (Pubitemid 29024005)
173. Fishman S L., Murray J M., Eng F J., Walewski J L., Morgello S, Branch A D. Molecular and bioinformatic evidence of hepatitis C virus evolution in brain. J Infect Dis 2008 197 4 597-607 (Pubitemid 351321539)
174. Waddle D M. Matrix correlation tests support a single origin for modern humans. Nature 1994 368 6470 452-454
175. Laskus T, Radkowski M, Bednarska A et al. Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J Virol 2002 76 19 10064-10068 (Pubitemid 35006549)
176. Forton D M., Karayiannis P, Mahmud N, Taylor-Robinson S D., Thomas H C. Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol 2004 78 10 5170-5183 (Pubitemid 38581469)
177. Lerat H, Shimizu Y K., Lemon S M. Cell type-specific enhancement of hepatitis C virus internal ribosome entry site-directed translation due to 5 nontranslated region substitutions selected during passage of virus in lymphoblastoid cells. J Virol 2000 74 15 7024-7031 (Pubitemid 30470685)
178. Laporte J, Malet I, Andrieu T et al. Comparative analysis of translation efficiencies of hepatitis C virus 5 untranslated regions among intraindividual quasispecies present in chronic infection: opposite behaviors depending on cell type. J Virol 2000 74 22 10827-10833
179. Laporte J, Bain C, Maurel P, Inchauspe G, Agut H, Cahour A. Differential distribution and internal translation efficiency of hepatitis C virus quasispecies present in dendritic and liver cells. Blood 2003 101 1 52-57 (Pubitemid 36025886)
180. Di Liberto G, Roque-Afonso A M., Kara R et al. Clinical and therapeutic implications of hepatitis C virus compartmentalization. Gastroenterology 2006 131 1 76-84 (Pubitemid 44015750)
181. Ramirez S, Perez-Del-Pulgar S, Carrion J A. et al. Hepatitis C virus compartmentalization and infection recurrence after liver transplantation. Am J Transplant 2009 9 7 1591-1601
182. Kurosaki M, Enomoto N, Sakamoto N et al. Detection and analysis of replicating hepatitis C virus RNA in hepatocellular carcinoma tissues. J Hepatol 1995 22 5 527-535
183. De Mitri M S., Mele L, Chen C H. et al. Comparison of serum and liver hepatitis C virus quasispecies in HCV-related hepatocellular carcinoma. J Hepatol 1998 29 6 887-892 (Pubitemid 28559057)
184. De Mitri M S., Cassini R, Bagaglio S et al. Evolution of hepatitis C virus non-structural 5A gene in the progression of liver disease to hepatocellular carcinoma. Liver Int 2007 27 8 1126-1133 (Pubitemid 47399448)
185. Sobesky R, Feray C, Rimlinger F et al. Distinct hepatitis C virus core and F protein quasispecies in tumoral and nontumoral hepatocytes isolated via microdissection. Hepatology 2007 46 6 1704-1712
186. Afdhal N H., McHutchison J G., Zeuzem S et al, Pharmacogenetics and Hepatitis C Meeting Participants. Hepatitis C pharmacogenetics: state of the art in 2010. Hepatology 2011 53 1 336-345
187. Ge D, Fellay J, Thompson A J. et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009 461 7262 399-401
188. Tanaka Y, Nishida N, Sugiyama M et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 2009 41 10 1105-1109
189. Suppiah V, Moldovan M, Ahlenstiel G et al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 2009 41 10 1100-1104
190. Thomas D L., Thio C L., Martin M P. et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009 461 7265 798-801
191. Wohnsland A, Hofmann W P., Sarrazin C. Viral determinants of resistance to treatment in patients with hepatitis C. Clin Microbiol Rev 2007 20 1 23-38 (Pubitemid 46167766)
192. Okada S, Akahane Y, Suzuki H, Okamoto H, Mishiro S. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 1992 16 3 619-624
193. Kanazawa Y, Hayashi N, Mita E et al. Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients. Hepatology 1994 20 5 1121-1130 (Pubitemid 24323555)
194. Moribe T, Hayashi N, Kanazawa Y et al. Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy. Gastroenterology 1995 108 3 789-795
195. Nagasaka A, Hige S, Tsunematsu I et al. Changes in hepatitis C virus quasispecies and density populations in patients before and after interferon therapy. J Med Virol 1996 50 3 214-220 (Pubitemid 26384093)
196. Polyak S J., Faulkner G, Carithers R L. Jr, Corey L, Gretch D R. Assessment of hepatitis C virus quasispecies heterogeneity by gel shift analysis: correlation with response to interferon therapy. J Infect Dis 1997 175 5 1101-1107 (Pubitemid 27176497)
197. Le Guen B, Squadrito G, Nalpas B et al. Hepatitis C virus genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C. Hepatology 1997 25 5 1250-1254 (Pubitemid 27199956)
198. Pawlotsky J M., Pellerin M, Bouvier M et al. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C. J Med Virol 1998 54 4 256-264 (Pubitemid 28185417)
199. Hino K, Yamaguchi Y, Fujiwara D et al. Hepatitis C virus quasispecies and response to interferon therapy in patients with chronic hepatitis C: a prospective study. J Viral Hepat 2000 7 1 36-42 (Pubitemid 30139850)
200. Chambers T J., Fan X, Droll D A. et al. Quasispecies heterogeneity within the E1/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection. J Virol 2005 79 5 3071-3083 (Pubitemid 40270586)
201. Morishima C, Polyak S J., Ray R et al, Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial Group. Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C. J Infect Dis 2006 193 7 931-940
202. Torres-Puente M, Cuevas J M., Jiménez-Hernández N et al. Genetic variability in hepatitis C virus and its role in antiviral treatment response. J Viral Hepat 2008 15 3 188-199 (Pubitemid 351146581)
203. Moreau I, Levis J, Crosbie O, Kenny-Walsh E, Fanning L J. Correlation between pre-treatment quasispecies complexity and treatment outcome in chronic HCV genotype 3a. Virol J 2008 5 78
204. Saludes V, Bracho M A., Valero O et al. Baseline prediction of combination therapy outcome in hepatitis C virus 1b infected patients by discriminant analysis using viral and host factors. PLoS ONE 2010 5 11 e14132
205. Nakazawa T, Kato N, Ohkoshi S, Shibuya A, Shimotohno K. Characterization of the 5 noncoding and structural region of the hepatitis C virus genome from patients with non-A, non-B hepatitis responding differently to interferon treatment. J Hepatol 1994 20 5 623-629 (Pubitemid 24149022)
206. López-Labrador F X., Ampurdanis S, Giménez-Barcons M et al. Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection [correction of interferon]. Hepatology 1999 29 3 897-903 (Pubitemid 29109607)
207. Sandres K, Dubois M, Pasquier C et al. Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy. J Virol 2000 74 2 661-668 (Pubitemid 30036201)
208. Fan X, Mao Q, Zhou D et al. High diversity of hepatitis C viral quasispecies is associated with early virological response in patients undergoing antiviral therapy. Hepatology 2009 50 6 1765-1772
209. Polyak S J., McArdle S, Liu S L. et al. Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection. J Virol 1998 72 5 4288-4296 (Pubitemid 28188735)
210. Pawlotsky J M., Germanidis G, Frainais P O. et al. Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy. J Virol 1999 73 8 6490-6499 (Pubitemid 29327829)
211. Abbate I, Lo Iacono O, Di Stefano R et al. HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin. J Hepatol 2004 40 5 831-836 (Pubitemid 38507365)
212. Sherman K E., Rouster S D., Stanford S et al, AIDS Clinical Trials Group 5071 Study Team. Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens. J Infect Dis 2010 201 5 712-719
213. Thelu M A., Baud M, Leroy V, Seigneurin J M., Zarski J P. Dynamics of viral quasispecies during interferon therapy in non responder chronic hepatitis C patients. J Clin Virol 2001 22 1 125-131 (Pubitemid 32551956)
214. Enomoto N, Sakuma I, Asahina Y et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest 1995 96 1 224-230
215. Enomoto N, Sakuma I, Asahina Y et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 1996 334 2 77-81 (Pubitemid 26017933)
216. Sáiz J C., López-Labrador F X., Ampurdanés S et al. The prognostic relevance of the nonstructural 5A gene interferon sensitivity determining region is different in infections with genotype 1b and 3a isolates of hepatitis C virus. J Infect Dis 1998 177 4 839-847 (Pubitemid 28155134)
217. Puig-Basagoiti F, Sáiz J C., Forns X et al. Influence of the genetic heterogeneity of the ISDR and PePHD regions of hepatitis C virus on the response to interferon therapy in chronic hepatitis C. J Med Virol 2001 65 1 35-44
218. Hayashi K, Katano Y, Honda T et al. Mutations in the interferon sensitivity-determining region of hepatitis C virus genotype 2a correlate with response to pegylated-interferon-alpha 2a monotherapy. J Med Virol 2009 81 3 459-466
219. Khorsi H, Castelain S, Wyseur A et al. Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients. J Hepatol 1997 27 1 72-77 (Pubitemid 27357057)
220. Squadrito G, Leone F, Sartori M et al. Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa. Gastroenterology 1997 113 2 567-572 (Pubitemid 27351784)
221. Jardim A C., Yamasaki L H., de Queiróz A T. et al. Quasispecies of hepatitis C virus genotype 1 and treatment outcome with peginterferon and ribavirin. Infect Genet Evol 2009 9 4 689-698
222. Halfon P, Locarnini S. Hepatitis C virus resistance to protease inhibitors. J Hepatol 2011 55 1 192-206
223. Wainberg M A., Zaharatos G J., Brenner B G. Development of antiretroviral drug resistance. N Engl J Med 2011 365 7 637-646
224. Sarrazin C, Kieffer T L., Bartels D et al. Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir. Gastroenterology 2007 132 5 1767-1777 (Pubitemid 46677938)
225. Bartels D J., Zhou Y, Zhang E Z. et al. Natural prevalence of hepatitis C virus variants with decreased sensitivity to NS3.4A protease inhibitors in treatment-naive subjects. J Infect Dis 2008 198 6 800-807
226. Kuntzen T, Timm J, Berical A et al. Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naive patients. Hepatology 2008 48 6 1769-1778
227. Cubero M, Esteban J I., Otero T et al. Naturally occurring NS3-protease-inhibitor resistant mutant A156T in the liver of an untreated chronic hepatitis C patient. Virology 2008 370 2 237-245 (Pubitemid 350192568)
228. Kim A Y., Timm J, Nolan B E. et al. Temporal dynamics of a predominant protease inhibitor-resistance mutation in a treatment-naive, hepatitis C virus-infected individual. J Infect Dis 2009 199 5 737-741
229. Nijhuis M, van Maarseveen N M., Boucher C A. Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases. Handb Exp Pharmacol 2009 189 189 299-320
230. Shimakami T, Welsch C, Yamane D et al. Protease inhibitor-resistant hepatitis C virus mutants with reduced fitness from impaired production of infectious virus. Gastroenterology 2011 140 2 667-675